BackNavidea Biopharmaceuticals Overview

Navidea Biopharmaceuticals Cost of Revenue

Cost of Revenue analysis for NAVB.

Quarterly Cost of Revenue

N/A

As of Sep 30, 2023

Annual Cost of Revenue (TTM)

$-132970.00
↓ 198.56% YoY

Trailing 12 months ending Sep 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin